The goals of comprehensive and integrated disease state management for diabetic kidney-disease patients

被引:3
|
作者
Goeddeke-Merickel, CM
机构
[1] Maple Grove, MN 55369
关键词
diabetes; kidney disease; cardiovascular disease; hypertension; nutrition therapy;
D O I
10.1053/j.ackd.2005.01.006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Diabetes, cardiovascular disease, and chronic kidney disease present many challenges to clinicians as separate disease entities. Management and optimization of care of diabetic kidney-disease patients requires a proactive and integrated approach for all 3 disease states. To optimize the assessment, monitoring, and intervention in this population, comprehensive and integrated disease state management medical care plans must be established. Medical nutrition therapy is another key component that must be coordinated with these disease-state management medical care plans. Coordination of integrated disease-state management and medical nutrition therapy for diabetes, cardiovascular disease, and chronic kidney disease will help to improve patient outcomes and allow for a proactive approach to the identification, prevention, and management of potential disease-state complications. Several programs and guidelines have been established to accomplish these goals: the K/DOQI Clinical Practice Guidelines, the American Diabetes Association Standards of Medical Care for Diabetes (developed by the American Diabetes Association, the National Institute of Diabetes and Digestive Kidney Diseases, and the Centers for Disease Control-Diabetes Foundation), the National Diabetes Education Program, and the National Cholesterol Education Program. The multidisciplinary medical care team assumes an integral role in the success and implementation of this integrated approach as well as the empowerment of the patient in their own care. (c) 2005 by the National Kidney Foundation, Inc.
引用
收藏
页码:236 / 242
页数:7
相关论文
共 50 条
  • [1] TREATMENT OF DIABETIC KIDNEY-DISEASE
    GOETZ, FC
    KJELLSTRAND, CM
    DIABETOLOGIA, 1979, 17 (05) : 267 - 281
  • [2] MANAGEMENT OF HYPERLIPIDEMIA OF KIDNEY-DISEASE
    GRUNDY, SM
    KIDNEY INTERNATIONAL, 1990, 37 (03) : 847 - 853
  • [3] KINETICS AND EFFICACY OF GLIMEPIRIDE IN DIABETIC-PATIENTS WITH KIDNEY-DISEASE
    ROSENKRANZ, B
    MALERCZYK, V
    LEHR, KH
    RINGOIR, S
    LAMEIRE, NH
    METELKO, Z
    PROFOZIC, V
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 207 - 207
  • [4] DIABETIC KIDNEY-DISEASE IN PIMA-INDIANS
    NELSON, RG
    KNOWLER, WC
    PETTITT, DJ
    SAAD, MF
    BENNETT, PH
    DIABETES CARE, 1993, 16 (01) : 335 - 341
  • [5] POLYCYSTIC KIDNEY-DISEASE - DIAGNOSIS AND MANAGEMENT
    CHESTER, AC
    ARGY, WP
    SOUTHERN MEDICAL JOURNAL, 1979, 72 (12) : 1582 - 1586
  • [6] Management of glycemia in diabetic patients with diabetic kidney disease
    Liu Fang
    Fu Ping
    CHINESE MEDICAL JOURNAL, 2014, 127 (06) : 1170 - 1176
  • [7] Management of glycemia in diabetic patients with diabetic kidney disease
    Liu Fang
    Fu Ping
    中华医学杂志(英文版), 2014, 127 (06) : 1170 - 1176
  • [8] KIDNEY-DISEASE
    MIHATSCH, MJ
    ZOLLINGER, HU
    PATHOLOGY RESEARCH AND PRACTICE, 1980, 167 (01) : 88 - 117
  • [9] Management Strategies for Patients with Diabetic Kidney Disease and Chronic Kidney Disease in Diabetes
    Williams, Jessica K. Yakush
    NURSING CLINICS OF NORTH AMERICA, 2017, 52 (04) : 575 - +
  • [10] ANESTHESIA IN PATIENTS WITH LIVER OR KIDNEY-DISEASE
    OSSWALD, PM
    ANASTHESIE INTENSIVTHERAPIE NOTFALLMEDIZIN, 1982, 17 (05): : 269 - 272